ABBEYWELL SURGERY
THE ABBEY, ROMSEY
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 7 | 7 | 100.0% | |
| HF 4 | 2011 | 9 | 11 | 81.8% | |
| HF 4 | 2012 | 12 | 13 | 92.3% | |
| HF 4 | 2013 | 11 | 14 | 78.6% | |
| HF004 | 2014 | 7 | 7 | 100.0% | |
| HF004 | 2015 | 17 | 19 | 89.5% | |
| HF004 | 2016 | 17 | 17 | 100.0% | |
| HF004 | 2017 | 18 | 18 | 100.0% | |
| HF004 | 2018 | 42 | 45 | 93.3% | |
| HF004 | 2019 | 39 | 41 | 95.1% | |
| HF004 | 2020 | 43 | 45 | 95.6% | |
| HF006 | 2021 | 46 | 51 | 90.2% | |
| HF006 | 2022 | 51 | 51 | 100.0% | |
| HF006 | 2023 | 139 | 155 | 89.7% |
